Berman tabacco announces investigation of applied therapeutics, inc. (aplt) for potential securities law violations

Boston, massachusetts--(newsfile corp. - january 4, 2022) -  berman tabacco, a national law firm representing investors, is investigating potential securities law violations by applied therapeutics, inc. ("at" or the "company") (nasdaq: aplt), a clinical-stage biopharmaceutical company with headquarters in new york, new york.on january 3, 2022, before the market opened, the company issued a press release providing a regulatory update on the company's at-007 galactosemia program. the company stated, among other things, that "[f]ollowing...
APLT Ratings Summary
APLT Quant Ranking